Literature DB >> 30301521

Risk factors for systemic inflammatory response syndrome after percutaneous nephrolithotomy.

Z He1, F Tang2, H Lei2, Y Chen3, G Zeng2.   

Abstract

OBJECTIVES: To explore the risk factors for systemic inflammatory response syndrome (SIRS) after percutaneous nephrolithotomy (PCNL).
METHODS: A retrospective chart review was performed to identify 1030 patients who had undergone PCNL from January 2014 to July 2016 in the Minimally Invasive Surgery Center. Multiple data, including age, sex, body mass index (BMI), operation time, Staghorn calculi, diabetes, Serun creatinine, preoperative urine culture and the urinary sediment microscopy white blood cell (WBC) were collected. These factors and postoperative SIRS were retrospectively analyzed.
RESULTS: There were 108 cases (10.49%) of SIRS among 1030 patients. The results of univariate analysis showed that sex (P=0.015), Staghorn calculi (P<0.001), preoperative urinary culture of Gram-negative bacteria (P<0.001) and preoperative urinary sediment microscopy WBC (+, ++, +++, ++++) (P<0.001, P<0.001, P=0.009, P=0.045) were correlated with postoperative SIRS (P<0.05). According to Multivariate analysis results, the likelihood of SIRS after PCNL increased with Staghorn calculi (P=0.01, OR=10.457, 95% CI=1.312-3.092), the urinary sediment microscopy WBC (+∼++++) (P<0.001, OR=2.591, 95% CI=1.661-4.042) and positive urine culture for Gram-negative bacteria (P<0.001, OR=3.550, 95% CI=2.205-5.715).
CONCLUSIONS: Staghorn calculi, the urinary sediment microscopy WBC and positive urine culture for Gram-negative bacteria are independent risk factors for SIRS. Patients affected by these risk factors should receive careful anti-infectious perioperative management for prevention of postoperative SIRS. LEVEL OF INCIDENCE: 4.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Facteur de risque; Microscopie préopératoire des sédiments urinaires; PCNL; Preoperative urinary sediment microscopy; Risk factor; SIRS; WBC

Mesh:

Year:  2018        PMID: 30301521     DOI: 10.1016/j.purol.2018.06.006

Source DB:  PubMed          Journal:  Prog Urol        ISSN: 1166-7087            Impact factor:   0.915


  7 in total

1.  Preoperative risk factors for complications of percutaneous nephrolithotomy.

Authors:  Ahmed R El-Nahas; Mohamed A Nabeeh; Mahmoud Laymon; Khaled Z Sheir; Hamdy A El-Kappany; Yasser Osman
Journal:  Urolithiasis       Date:  2020-08-01       Impact factor: 3.436

2.  Comparison of stress response following microwave ablation and surgical resection of benign thyroid nodules.

Authors:  Shu-Yan Liu; Wei-Hong Guo; Bo Yang; Yong-Feng Li; Xiao-Yun Huang; Xiao-Qing Wang; Jie Chen; Dan Xue; Xue-Hong Zhou
Journal:  Endocrine       Date:  2019-03-23       Impact factor: 3.633

3.  Gender-related differences in the performance of sequential organ failure assessment (SOFA) to predict septic shock after percutaneous nephrolithotomy.

Authors:  Rong Shen; Wei Zhang; Shaoxiong Ming; Ling Li; Yonghan Peng; Xiaofeng Gao
Journal:  Urolithiasis       Date:  2020-05-05       Impact factor: 3.436

4.  Impact Factors and an Efficient Nomogram for Predicting the Occurrence of Sepsis after Percutaneous Nephrolithotomy.

Authors:  Jun Wang; Yuanyuan Mi; Sheng Wu; Hongbao Shao; Lijie Zhu; Feng Dai
Journal:  Biomed Res Int       Date:  2020-12-22       Impact factor: 3.411

5.  Value of preoperative urine white blood cell and nitrite in predicting postoperative infection following percutaneous nephrolithotomy: a meta-analysis.

Authors:  Shuhao Ruan; Zhiyong Chen; Zewu Zhu; Huimin Zeng; Jinbo Chen; Hequn Chen
Journal:  Transl Androl Urol       Date:  2021-01

6.  Ginkgolide A Participates in LPS-Induced PMVEC Injury by Regulating miR-224 and Inhibiting p21 in a Targeted Manner.

Authors:  Zhonglin Liu; Yan Yang
Journal:  Contrast Media Mol Imaging       Date:  2022-09-10       Impact factor: 3.009

7.  The Predictive Value of Preoperative Albumin-Globulin Ratio for Systemic Inflammatory Response Syndrome After Percutaneous Nephrolithotomy.

Authors:  Qing Wang; Kehua Jiang; Xiaolong Chen; Guohua Zeng; Fa Sun
Journal:  Int J Gen Med       Date:  2022-09-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.